Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC - Concepedia

Concepedia

Publication | Open Access

Phase 3 Trial of BI 695502 Plus Chemotherapy Versus Bevacizumab Reference Product Plus Chemotherapy in Patients With Advanced Nonsquamous NSCLC

DOI Full Paper Access

10

Citations

19

References

2021

Year

Edward S. Kim, Sigrid Balser, Klaus Röhr, Ragna Lohmann, Bernd Liedert, Dorothee E. Schliephake

JTO Clinical and Research Reports

References

	Year	Citations

Page 1